Literature DB >> 23178685

Negative regulation of ERα by a novel protein CAC1 through association with histone demethylase LSD1.

JuHyun Kim1, Ui-Hyun Park, MinO Moon, Soo-Jong Um, Eun-Joo Kim.   

Abstract

ERα, a critical transcriptional factor for breast cancer proliferation, is regulated by a complex binding repertoire that includes coactivators and corepressors. Here, we identified a novel class of ERα coregulator called CAC1. The CoRNR box of CAC1 was required for the binding to and inactivation of ERα. CAC1 also associated with histone demethylase LSD1 and suppressed LSD1-enhanced ERα activity. CAC1 impaired recruitment of ERα and LSD1 to the ERα-responsive promoter, leading to greater H3K9me3 accumulation. This effect was reversed by CAC1 depletion. Finally, CAC1 increased paclitaxel-induced cell death in ERα-positive MCF7 cells, which are paclitaxel-resistant. Overall, our study provides the first evidence that CAC1, associated with LSD1, functions as an ERα corepressor, implicating a potential antitumor target in ERα-positive breast cancer.
Copyright © 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23178685     DOI: 10.1016/j.febslet.2012.10.054

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  10 in total

Review 1.  KDM1 class flavin-dependent protein lysine demethylases.

Authors:  Jonathan M Burg; Jennifer E Link; Brittany S Morgan; Frederick J Heller; Amanda E Hargrove; Dewey G McCafferty
Journal:  Biopolymers       Date:  2015-07       Impact factor: 2.505

2.  Synergistic antitumor effect of 5-fluorouracil with the novel LSD1 inhibitor ZY0511 in colorectal cancer.

Authors:  Wen Peng; Huaqing Zhang; Shisheng Tan; Yan Li; Yang Zhou; Liang Wang; Chunqi Liu; Qiu Li; Xiaobo Cen; Shengyong Yang; Yinglan Zhao
Journal:  Ther Adv Med Oncol       Date:  2020-07-23       Impact factor: 8.168

Review 3.  Epigenetic regulation of LSD1 during mammary carcinogenesis.

Authors:  Yadi Wu; Binhua P Zhou
Journal:  Mol Cell Oncol       Date:  2014-12-23

4.  CACUL1 reciprocally regulates SIRT1 and LSD1 to repress PPARγ and inhibit adipogenesis.

Authors:  Min Jun Jang; Ui-Hyun Park; Jeong Woo Kim; Hanbyeul Choi; Soo-Jong Um; Eun-Joo Kim
Journal:  Cell Death Dis       Date:  2017-12-11       Impact factor: 8.469

Review 5.  KDM1A microenvironment, its oncogenic potential, and therapeutic significance.

Authors:  Tayaba Ismail; Hyun-Kyung Lee; Chowon Kim; Taejoon Kwon; Tae Joo Park; Hyun-Shik Lee
Journal:  Epigenetics Chromatin       Date:  2018-06-19       Impact factor: 4.954

Review 6.  Pharmacological Inhibition of LSD1 for Cancer Treatment.

Authors:  Guan-Jun Yang; Pui-Man Lei; Suk-Yu Wong; Dik-Lung Ma; Chung-Hang Leung
Journal:  Molecules       Date:  2018-12-04       Impact factor: 4.411

Review 7.  A state-of-the-art review on LSD1 and its inhibitors in breast cancer: Molecular mechanisms and therapeutic significance.

Authors:  Guan-Jun Yang; Yan-Jun Liu; Li-Jian Ding; Fan Tao; Ming-Hui Zhu; Zhen-Yuan Shi; Juan-Ming Wen; Meng-Yao Niu; Xiang Li; Zhan-Song Xu; Wan-Jia Qin; Chen-Jie Fei; Jiong Chen
Journal:  Front Pharmacol       Date:  2022-09-16       Impact factor: 5.988

8.  CACUL1/CAC1 Regulates the Antioxidant Response by Stabilizing Nrf2.

Authors:  Yu Kigoshi; Tomomi Fukuda; Tomoyuki Endo; Nami Hayasaka; Shun-ichiro Iemura; Toru Natsume; Fuminori Tsuruta; Tomoki Chiba
Journal:  Sci Rep       Date:  2015-08-04       Impact factor: 4.379

9.  CAC1 knockdown reverses drug resistance through the downregulation of P-gp and MRP-1 expression in colorectal cancer.

Authors:  Nanzheng Chen; Ying Kong; Yunhua Wu; Qi Gao; Junke Fu; Xuejun Sun; Qianqian Geng
Journal:  PLoS One       Date:  2019-09-10       Impact factor: 3.240

10.  Inhibition of Histone Demethylases LSD1 and UTX Regulates ERα Signaling in Breast Cancer.

Authors:  Rosaria Benedetti; Carmela Dell'Aversana; Tommaso De Marchi; Dante Rotili; Ning Qing Liu; Boris Novakovic; Serena Boccella; Salvatore Di Maro; Sandro Cosconati; Alfonso Baldi; Emma Niméus; Johan Schultz; Urban Höglund; Sabatino Maione; Chiara Papulino; Ugo Chianese; Francesco Iovino; Antonio Federico; Antonello Mai; Hendrik G Stunnenberg; Angela Nebbioso; Lucia Altucci
Journal:  Cancers (Basel)       Date:  2019-12-16       Impact factor: 6.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.